
News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
Method Validation by Phase of Development: An Acceptable Analytical Practice
This article provides guidance for minimally acceptable method validation practices and a foundation for assessing the risks and benefits associated with method validation programs.
Advertisement
Articles in this issue
over 21 years ago
Still Waiting for Answersover 21 years ago
Comparing and Contrasting Barrier Isolator Decontamination Systemsover 21 years ago
November 2004over 21 years ago
In the Spotlight-November 2004over 21 years ago
Searching for a Viable Business Modelover 21 years ago
FDA Moves To Implement New GMP PoliciesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
Women in STEM: Early Phase Drug Development
4
PharmTech Weekly Roundup - February 6, 2026
5




